Fernwood Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-174,724
| Closed | -$11.9M | – | 191 |
|
|
2022
Q3 | $11.9M | Sell |
174,724
-28,026
| -14% | -$1.55M | 5.02% | 2 |
|
|
2022
Q2 | $6.48M | Sell |
202,750
-7,225
| -3% | -$211K | 2.79% | 4 |
|
|
2022
Q1 | $7.27M | Sell |
209,975
-375
| -0.2% | -$11.2K | 2.55% | 6 |
|
|
2021
Q4 | $6.16M | Sell |
210,350
-2,775
| -1% | -$86K | 2.01% | 8 |
|
|
2021
Q3 | $5.43M | Buy |
213,125
+5,000
| +2% | +$147K | 1.87% | 11 |
|
|
2021
Q2 | $7.29M | Buy |
208,125
+1,518
| +0.7% | +$59.3K | 2.41% | 9 |
|
|
2021
Q1 | $8.42M | Buy |
206,607
+4,950
| +2% | +$228K | 3.1% | 3 |
|
|
2020
Q4 | $8.73M | Buy |
201,657
+14,180
| +8% | +$699K | 3.44% | 2 |
|
|
2020
Q3 | $10.3M | Sell |
187,477
-8,900
| -5% | -$566K | 4.88% | 1 |
|
|
2020
Q2 | $12.4M | Sell |
196,377
-8,535
| -4% | -$585K | 6.13% | 1 |
|
|
2020
Q1 | $10.5M | Sell |
204,912
-53,100
| -21% | -$3.56M | 6.68% | 1 |
|
|
2019
Q4 | $20.5M | Sell |
258,012
-70,550
| -21% | -$4.18M | 9.81% | 1 |
|
|
2019
Q3 | $15.9M | Buy |
328,562
+657
| +0.2% | +$34.2K | 7.9% | 1 |
|
|
2019
Q2 | $17.2M | Buy |
327,905
+3,028
| +0.9% | +$174K | 9.44% | 1 |
|
|
2019
Q1 | $17.2M | Sell |
324,877
-32,335
| -9% | -$1.59M | 9.17% | 1 |
|
|
2018
Q4 | $14.7M | Sell |
357,212
-26,490
| -7% | -$993K | 9.45% | 1 |
|
|
2018
Q3 | $14.6M | Buy |
383,702
+27,633
| +8% | +$1.22M | 7.71% | 1 |
|
|
2018
Q2 | $16.1M | Buy |
356,069
+560
| +0.2% | +$25.5K | 8.69% | 1 |
|
|
2018
Q1 | $17.2M | Sell |
355,509
-3,585
| -1% | -$200K | 9.58% | 1 |
|
|
2017
Q4 | $14.1M | Sell |
359,094
-58,916
| -14% | -$2.2M | 7.56% | 1 |
|
|
2017
Q3 | $13M | Buy |
418,010
+136,553
| +49% | +$3.84M | 8.13% | 1 |
|
|
2017
Q2 | $7.7M | Buy |
281,457
+18,947
| +7% | +$564K | 5.58% | 2 |
|
|
2017
Q1 | $9.67M | Buy |
262,510
+205,026
| +357% | +$5.16M | 7.7% | 1 |
|
|
2016
Q4 | $831K | Buy |
57,484
+17,484
| +44% | +$307K | 0.8% | 42 |
|
|
2016
Q3 | $922K | Buy |
40,000
+100
| +0.3% | +$1.91K | 0.84% | 42 |
|
|
2016
Q2 | $662K | Buy |
39,900
+19,950
| +100% | +$402K | 0.65% | 49 |
|
|
2016
Q1 | $316K | Buy |
+19,950
| New | +$354K | 0.32% | 79 |
|
Other funds holding GBT
Fernwood Investment Management's GBT Position: Q4 2022 in Review
Fernwood Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 174,724 shares — an estimated $11.9M sold.
Fernwood Investment Management first reported a position in GBT in Q1 2016 and held it in 27 quarters. The position peaked at $20.5M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Fernwood Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Fernwood Investment Management sold 174,724 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $11.9M.
- Fernwood Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 27 quarters.
- Fernwood Investment Management's Global Blood Therapeutics, Inc. position peaked at $20.5M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Fernwood Investment Management's 13F filing for Q4 2022, filed 7 Feb 2023.